eFFECTOR Therapeutics, Inc.

Organization

Kawasaki-shi, JP

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Crystalline forms of Mnk inhibitors
- Patent number 11,952,375
- Issue date Apr 9, 2024
- eFFECTOR Therapeutics Inc.
- Siegfried H. Reich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine-substituted Mnk inhibitors and methods related thereto
- Patent number 11,878,015
- Issue date Jan 23, 2024
- eFFECTOR Therapeutics Inc.
- Justin T. Ernst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for an improved antitumor immune response
- Patent number 11,576,933
- Issue date Feb 14, 2023
- eFFECTOR Therapeutics Inc.
- Peggy A. Thompson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for cellular immunotherapy
- Patent number 11,564,947
- Issue date Jan 31, 2023
- eFFECTOR Therapeutics Inc.
- Kevin R. Webster
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EIF4A-inhibiting compounds and methods related thereto
- Patent number 11,440,917
- Issue date Sep 13, 2022
- eFFECTOR THERAPEUTICS, INC.
- Justin T. Ernst
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EIF4E-inhibiting compounds and methods
- Patent number 11,286,268
- Issue date Mar 29, 2022
- eFFECTOR THERAPEUTICS, INC.
- Samuel Sperry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of MNK inhibitors
- Patent number 11,130,757
- Issue date Sep 28, 2021
- eFFECTOR Therapeutics Inc.
- Siegfried H. Reich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine-substituted Mnk inhibitors and methods related thereto
- Patent number 11,083,727
- Issue date Aug 10, 2021
- eFFECTOR Therapeutics Inc.
- Justin T. Ernst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that...
- Patent number 11,014,926
- Issue date May 25, 2021
- eFFECTOR THERAPEUTICS, INC.
- Paul A. Sprengeler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzimidazole-indole inhibitors of Mnk1 and Mnk2
- Patent number 10,793,551
- Issue date Oct 6, 2020
- eFFECTOR Therapeutics Inc.
- Justin T. Ernst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for cellular immunotherapy
- Patent number 10,780,119
- Issue date Sep 22, 2020
- eFFECTOR Therapeutics Inc.
- Kevin R. Webster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of immune checkpoint modulators and related methods
- Patent number 10,702,526
- Issue date Jul 7, 2020
- eFFECTOR Therapeutics Inc.
- Kevin R. Webster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EIF4A-inhibiting compounds and methods related thereto
- Patent number 10,577,378
- Issue date Mar 3, 2020
- eFFECTOR THERAPEUTICS, INC.
- Justin T. Ernst
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating fibrotic disease
- Patent number 10,576,098
- Issue date Mar 3, 2020
- eFFECTOR Therapeutics Inc.
- James Appleman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone...
- Patent number 10,112,955
- Issue date Oct 30, 2018
- eFFECTOR THERAPEUTICS, INC.
- Paul A. Sprengeler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds that inhibit the kinase activity of Mnk usef...
- Patent number 10,000,487
- Issue date Jun 19, 2018
- eFFECTOR THERAPEUTICS, INC.
- Paul A. Sprengeler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating fibrotic disease
- Patent number 9,993,494
- Issue date Jun 12, 2018
- eFFECTOR THERAPEUTICS, INC.
- James Appleman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
eIF4A-inhibiting compounds and methods related thereto
- Patent number 9,957,277
- Issue date May 1, 2018
- eFFECTOR THERAPEUTICS, INC.
- Justin T. Ernst
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MNK inhibitors and methods related thereto
- Patent number 9,814,718
- Issue date Nov 14, 2017
- eFFECTOR THERAPEUTICS, INC.
- Siegfried H. Reich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MNK inhibitors and methods related thereto
- Patent number 9,669,031
- Issue date Jun 6, 2017
- eFFECTOR THERAPEUTICS, INC.
- Siegfried H. Reich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mnk inhibitors and methods related thereto
- Patent number 9,382,248
- Issue date Jul 5, 2016
- eFFECTOR THERAPEUTICS, INC.
- Siegfried H. Reich
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Solid Forms of an eIF4E Inhibitor
- Publication number 20240076301
- Publication date Mar 7, 2024
- Pfizer Inc.
- Kapildev Kashmirilal Arora
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY
- Publication number 20230381232
- Publication date Nov 30, 2023
- eFFECTOR Therapeutics Inc.
- Kevin R. WEBSTER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO
- Publication number 20230295179
- Publication date Sep 21, 2023
- eFFECTOR Therapeutics, Inc.
- Justin T. ERNST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EIF4E-INHIBITING COMPOUNDS AND METHODS
- Publication number 20230108594
- Publication date Apr 6, 2023
- eFFECTOR Therapeutics, Inc.
- Samuel SPERRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO
- Publication number 20230071483
- Publication date Mar 9, 2023
- eFFECTOR Therapeutics Inc.
- Justin T. ERNST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING BRAF-MUTATED CANCER CELLS
- Publication number 20220378821
- Publication date Dec 1, 2022
- eFFECTOR Therapeutics, Inc.
- Kevin R. WEBSTER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CRYSTALLINE FORMS OF MNK INHIBITORS
- Publication number 20220119387
- Publication date Apr 21, 2022
- eFFECTOR Therapeutics Inc.
- Siegfried H. REICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINE-SUBSTITUTED MNK INHIBITORS AND METHODS RELATED THERETO
- Publication number 20220096472
- Publication date Mar 31, 2022
- eFFECTOR Therapeutics Inc.
- Justin T. Ernst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MNK INHIBITORS AND METHODS RELATED THERETO
- Publication number 20210338673
- Publication date Nov 4, 2021
- eFFECTOR Therapeutics Inc.
- Siegfried H. Reich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EIF4A INHIBITOR COMBINATIONS
- Publication number 20210299111
- Publication date Sep 30, 2021
- eFFECTOR Therapeutics Inc.
- Peggy A. Thompson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY
- Publication number 20210177898
- Publication date Jun 17, 2021
- eFFECTOR Therapeutics, Inc.
- Kevin R. WEBSTER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF IMMUNE CHECKPOINT MODULATORS AND RELATED METHODS
- Publication number 20210046074
- Publication date Feb 18, 2021
- eFFECTOR Therapeutics, Inc.
- Kevin R. Webster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MNK BIOMARKERS AND USES THEREOF
- Publication number 20210010086
- Publication date Jan 14, 2021
- eFFECTOR Therapeutics, Inc.
- Peggy A. Thompson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR AN IMPROVED ANTITUMOR IMMUNE RESPONSE
- Publication number 20200147135
- Publication date May 14, 2020
- eFFECTOR Therapeutics, Inc.
- Peggy A. THOMPSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF MNK INHIBITORS
- Publication number 20200131179
- Publication date Apr 30, 2020
- eFFECTOR Therapeutics Inc.
- Siegfried H. Reich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLO-, PYRAZOLO-, IMIDAZO-PYRIMIDINE AND PYRIDINE COMPOUNDS THAT...
- Publication number 20190330216
- Publication date Oct 31, 2019
- eFFECTOR Therapeutics, Inc.
- Paul A. Sprengeler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidine-Substituted Mnk Inhibitors and Methods Related Thereto
- Publication number 20190275039
- Publication date Sep 12, 2019
- eFFECTOR Therapeutics Inc.
- Justin T. Ernst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MNK INHIBITORS AND METHODS RELATED THERETO
- Publication number 20190209560
- Publication date Jul 11, 2019
- eFFECTOR Therapeutics, Inc.
- Siegfried H. Reich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF TRANSLATIONAL PROFILING TO IDENTIFY TARGET MOLECULES FOR THE...
- Publication number 20190136321
- Publication date May 9, 2019
- The Regents of the University of California
- Davide Ruggero
- G01 - MEASURING TESTING
Information Patent Application
BENZIMIDAZOLE-INDOLE INHIBITORS OF MNK1 AND MNK2
- Publication number 20190119256
- Publication date Apr 25, 2019
- eFFECTOR Therapeutics, Inc.
- Justin T. ERNST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING FIBROTIC DISEASE
- Publication number 20190038657
- Publication date Feb 7, 2019
- eFFECTOR Therapeutics, Inc.
- James Appleman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY
- Publication number 20180353545
- Publication date Dec 13, 2018
- eFFECTOR Therapeutics, Inc.
- Kevin R. WEBSTER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO
- Publication number 20180298017
- Publication date Oct 18, 2018
- eFFECTOR Therapeutics, Inc.
- Justin T. ERNST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidine-Substituted Mnk Inhibitors and Methods Related Thereto
- Publication number 20180228803
- Publication date Aug 16, 2018
- eFFECTOR Therapeutics, Inc.
- Justin T. ERNST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MNK INHIBITORS AND METHODS RELATED THERETO
- Publication number 20180085368
- Publication date Mar 29, 2018
- eFFECTOR Therapeutics, Inc.
- Siegfried H. Reich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MNK INHIBITORS AND METHODS RELATED THERETO
- Publication number 20170266185
- Publication date Sep 21, 2017
- eFFECTOR Therapeutics, Inc.
- Siegfried H. Reich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS
- Publication number 20170247692
- Publication date Aug 31, 2017
- eFFECTOR Therapeutics, Inc.
- James Appleman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MNK BIOMARKERS AND USES THEREOF
- Publication number 20170191136
- Publication date Jul 6, 2017
- eFFECTOR Therapeutics, Inc.
- Peggy A. Thompson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO
- Publication number 20170145026
- Publication date May 25, 2017
- eFFECTOR Therapeutics, Inc.
- Justin T. ERNST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS THAT INHIBIT THE KINASE ACTIVITY OF MNK USEF...
- Publication number 20170145009
- Publication date May 25, 2017
- eFFECTOR Therapeutics, Inc.
- Paul A. SPRENGELER
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks

Information Trademark
97796319 - EFFECTOR
- Serial number 97796319
- Registration number 7331588
- Filing date Feb 15, 2023
- eFFECTOR Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
87270238 - EFFECTOR
- Serial number 87270238
- Registration number 5404524
- Filing date Dec 15, 2016
- eFFECTOR Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
87083426 - EFFECTOR THERAPEUTICS
- Serial number 87083426
- Registration number 5145511
- Filing date Jun 24, 2016
- eFFECTOR Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
85627410 - EFFECTOR THERAPEUTICS
- Serial number 85627410
- Registration number 5027328
- Filing date May 16, 2012
- eFFECTOR Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto

eFFECTOR Therapeutics, Inc.

Organization

Patents Grantslast 30 patents

Crystalline forms of Mnk inhibitors

Piperidine-substituted Mnk inhibitors and methods related thereto

Compositions and methods for an improved antitumor immune response

Methods and compositions for cellular immunotherapy

EIF4A-inhibiting compounds and methods related thereto

EIF4E-inhibiting compounds and methods

Crystalline forms of MNK inhibitors

Piperidine-substituted Mnk inhibitors and methods related thereto

Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that...

Benzimidazole-indole inhibitors of Mnk1 and Mnk2

Methods and compositions for cellular immunotherapy

Inhibitors of immune checkpoint modulators and related methods

EIF4A-inhibiting compounds and methods related thereto

Compositions and methods for treating fibrotic disease

Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone...

Heterocyclic compounds that inhibit the kinase activity of Mnk usef...

Compositions and methods for treating fibrotic disease

eIF4A-inhibiting compounds and methods related thereto

MNK inhibitors and methods related thereto

MNK inhibitors and methods related thereto

Mnk inhibitors and methods related thereto

Patents Applicationslast 30 patents

Solid Forms of an eIF4E Inhibitor

METHODS AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY

EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO

EIF4E-INHIBITING COMPOUNDS AND METHODS

EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO

METHODS OF TREATING BRAF-MUTATED CANCER CELLS

CRYSTALLINE FORMS OF MNK INHIBITORS

PIPERIDINE-SUBSTITUTED MNK INHIBITORS AND METHODS RELATED THERETO

MNK INHIBITORS AND METHODS RELATED THERETO

EIF4A INHIBITOR COMBINATIONS

METHODS AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY

INHIBITORS OF IMMUNE CHECKPOINT MODULATORS AND RELATED METHODS

MNK BIOMARKERS AND USES THEREOF

COMPOSITIONS AND METHODS FOR AN IMPROVED ANTITUMOR IMMUNE RESPONSE

CRYSTALLINE FORMS OF MNK INHIBITORS

PYRROLO-, PYRAZOLO-, IMIDAZO-PYRIMIDINE AND PYRIDINE COMPOUNDS THAT...

Piperidine-Substituted Mnk Inhibitors and Methods Related Thereto

MNK INHIBITORS AND METHODS RELATED THERETO

USE OF TRANSLATIONAL PROFILING TO IDENTIFY TARGET MOLECULES FOR THE...

BENZIMIDAZOLE-INDOLE INHIBITORS OF MNK1 AND MNK2

COMPOSITIONS AND METHODS FOR TREATING FIBROTIC DISEASE

METHODS AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY

EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO

Piperidine-Substituted Mnk Inhibitors and Methods Related Thereto

MNK INHIBITORS AND METHODS RELATED THERETO

MNK INHIBITORS AND METHODS RELATED THERETO

COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS

MNK BIOMARKERS AND USES THEREOF

EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO

HETEROCYCLIC COMPOUNDS THAT INHIBIT THE KINASE ACTIVITY OF MNK USEF...

Trademarklast 30 trademarks

97796319 - EFFECTOR

87270238 - EFFECTOR

87083426 - EFFECTOR THERAPEUTICS

85627410 - EFFECTOR THERAPEUTICS